Literature DB >> 18703627

Kinesin superfamily-associated protein 3 is preferentially expressed in glutamatergic neurons and contributes to the excitatory control of female puberty.

Jungil Choi1, Chang Man Ha, Eun Jung Choi, Choon Soo Jeong, Jeong Woo Park, Ja-Hyun Baik, Jae-Yong Park, Maria E Costa, Sergio R Ojeda, Byung Ju Lee.   

Abstract

It was earlier shown that expression of kinesin superfamily-associated protein 3 (KAP3), involved in the neuronal anterograde, microtubule-dependent transport of membrane organelles, increases in the hypothalamus of female rats during the juvenile phase of sexual development. KAP3 mRNA is abundant in the hypothalamus, suggesting that it might be expressed in broadly disseminated neuronal systems controlling neuroendocrine function. The present study identifies one of these systems and provides evidence for an involvement of KAP3 in the excitatory control of female puberty. In situ hybridization and immunohistofluorescence studies revealed that the KAP3 gene is expressed in glutamatergic neurons but not in GABAergic or GnRH neurons. Hypothalamic KAP3 mRNA levels increase during the juvenile period of female prepubertal development, remaining elevated throughout puberty. These changes appear to be, at least in part, estradiol dependent because ovariectomy decreases and estradiol increases KAP3 mRNA abundance. Lowering hypothalamic KAP3 protein levels via intraventricular administration of an antisense oligodeoxynucleotide resulted in reduced release of both glutamate and GnRH from the median eminence and delayed the onset of puberty. The median eminence content of vesicular glutamate transporter 2, a glutamate neuron-selective synaptic protein, and synaptophysin, a synaptic vesicle marker, were also reduced, suggesting that the loss of KAP3 diminishes the anterograde transport of these proteins. Altogether, these results support the view that decreased KAP3 synthesis diminishes GnRH output and delays female sexual development by compromising hypothalamic release of glutamate.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703627      PMCID: PMC2613065          DOI: 10.1210/en.2008-0432

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  62 in total

Review 1.  Stirring up development with the heterotrimeric kinesin KIF3.

Authors:  N Hirokawa
Journal:  Traffic       Date:  2000-01       Impact factor: 6.215

2.  Organelle transport along microtubules - the role of KIFs.

Authors:  N Hirokawa
Journal:  Trends Cell Biol       Date:  1996-04       Impact factor: 20.808

3.  Monoclonal antibodies to luteinizing hormone-releasing hormone: production, characterization, and immunocytochemical application.

Authors:  H F Urbanski
Journal:  Biol Reprod       Date:  1991-04       Impact factor: 4.285

Review 4.  Axonal transport and the cytoskeleton.

Authors:  N Hirokawa
Journal:  Curr Opin Neurobiol       Date:  1993-10       Impact factor: 6.627

5.  Cloning and characterization of KAP3: a novel kinesin superfamily-associated protein of KIF3A/3B.

Authors:  H Yamazaki; T Nakata; Y Okada; N Hirokawa
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

6.  Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro.

Authors:  A O Donoso; F J López; A Negro-Vilar
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

7.  Endogenous excitatory amino acid neurotransmission regulates the estradiol-induced LH surge in ovariectomized rats.

Authors:  F J López; A O Donoso; A Negro-Vilar
Journal:  Endocrinology       Date:  1990-03       Impact factor: 4.736

8.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.

Authors:  S Takamori; J S Rhee; C Rosenmund; R Jahn
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Glutamate, the dominant excitatory transmitter in neuroendocrine regulation.

Authors:  A N van den Pol; J P Wuarin; F E Dudek
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  KIF3A/B: a heterodimeric kinesin superfamily protein that works as a microtubule plus end-directed motor for membrane organelle transport.

Authors:  H Yamazaki; T Nakata; Y Okada; N Hirokawa
Journal:  J Cell Biol       Date:  1995-09       Impact factor: 10.539

View more
  6 in total

Review 1.  A system biology approach to identify regulatory pathways underlying the neuroendocrine control of female puberty in rats and nonhuman primates.

Authors:  Alejandro Lomniczi; Hollis Wright; Juan Manuel Castellano; Kemal Sonmez; Sergio R Ojeda
Journal:  Horm Behav       Date:  2013-07       Impact factor: 3.587

2.  Gene networks and the neuroendocrine regulation of puberty.

Authors:  Sergio R Ojeda; Christopher Dubay; Alejandro Lomniczi; Gabi Kaidar; Valerie Matagne; Ursula S Sandau; Gregory A Dissen
Journal:  Mol Cell Endocrinol       Date:  2009-12-22       Impact factor: 4.102

3.  Hnrpab regulates neural development and neuron cell survival after glutamate stimulation.

Authors:  John R Sinnamon; Catherine B Waddell; Sara Nik; Emily I Chen; Kevin Czaplinski
Journal:  RNA       Date:  2012-02-13       Impact factor: 4.942

Review 4.  The transcriptional control of female puberty.

Authors:  Sergio R Ojeda; Alejandro Lomniczi; Alberto Loche; Valerie Matagne; Gabi Kaidar; Ursula S Sandau; Gregory A Dissen
Journal:  Brain Res       Date:  2010-09-17       Impact factor: 3.252

Review 5.  Leptin action in pubertal development: recent advances and unanswered questions.

Authors:  Carol F Elias
Journal:  Trends Endocrinol Metab       Date:  2011-10-04       Impact factor: 12.015

6.  Expression of Vesicular Glutamate Transporter 2 (vGluT2) on Large Dense-Core Vesicles within GnRH Neuroterminals of Aging Female Rats.

Authors:  Weiling Yin; Zengrong Sun; John M Mendenhall; Deena M Walker; Penny D Riha; Kelsey S Bezner; Andrea C Gore
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.